Purchase customized pilot scale continuous manufacturing equipment suitable for CO-extrusion of rod and hollow tube implants

Active Purchase Order Awarded Last action

Contract number
75F40123P00376
Awardee
Awarding agency
Obligated
$894,000

Award facts

Opportunity
  • 75F40123Q00123 Solicitation number
Contract value 100% obligated
$894,000.00 Current and potential, with all options
Completion date 93% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Calverton, MD 20705, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 $0
Original award $894,000

About this award

The Food and Drug Administration awarded a $894,000 firm fixed-price purchase order to Leistritz Advanced Technologies Corp, operating through its Leistritz Extrusion Division, for the procurement of customized pilot-scale continuous manufacturing equipment suitable for co-extrusion of rod and hollow tube implants. The contract, set aside for small businesses, carries an ultimate completion date of January 28, 2027, with performance to occur in Calverton, Maryland. This award supports the FDA's regulatory and research objectives by enabling the development and testing of advanced manufacturing capabilities for medical devices, specifically implant production technologies.

Leistritz Advanced Technologies Corp is a small business manufacturer specializing in extrusion technology and high-precision equipment for research, industrial, and governmental applications. The company has demonstrated substantial technical expertise across multiple federal agencies, including prior contract awards from the U.S. Department of Agriculture's Agricultural Research Service and the U.S. Army Research, Development and Engineering Command. The customized equipment procured under this contract will enable the FDA to advance its capabilities in medical implant manufacturing processes, supporting the agency's mission in device development and regulatory evaluation.

Quick answers

Who was awarded contract 75F40123P00376?

75F40123P00376 was awarded to Leistritz Advanced Technologies Corp by Food and Drug Administration (Department of Health and Human Services) on September 19, 2023.

How much is contract 75F40123P00376 worth?

The government has obligated $894,000 on 75F40123P00376.

Was contract 75F40123P00376 competed?

The extent of competition for 75F40123P00376 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award